Cargando…

Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model

Cardamonin, a naturally occurring chalcone isolated from Alpinia species has shown to possess strong anti-inflammatory and anti-nociceptive activities. Previous studies have demonstrated that cardamonin exerts antihyperalgesic and antiallodynic properties in chronic constriction injury (CCI)-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaswan, Nur Khalisah, Mohammed Izham, Noor Aishah Binti, Tengku Mohamad, Tengku Azam Shah, Sulaiman, Mohd Roslan, Perimal, Enoch Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234694/
https://www.ncbi.nlm.nih.gov/pubmed/34208700
http://dx.doi.org/10.3390/molecules26123677
_version_ 1783714143454363648
author Kaswan, Nur Khalisah
Mohammed Izham, Noor Aishah Binti
Tengku Mohamad, Tengku Azam Shah
Sulaiman, Mohd Roslan
Perimal, Enoch Kumar
author_facet Kaswan, Nur Khalisah
Mohammed Izham, Noor Aishah Binti
Tengku Mohamad, Tengku Azam Shah
Sulaiman, Mohd Roslan
Perimal, Enoch Kumar
author_sort Kaswan, Nur Khalisah
collection PubMed
description Cardamonin, a naturally occurring chalcone isolated from Alpinia species has shown to possess strong anti-inflammatory and anti-nociceptive activities. Previous studies have demonstrated that cardamonin exerts antihyperalgesic and antiallodynic properties in chronic constriction injury (CCI)-induced neuropathic pain animal model. However, the mechanisms underlying cardamonin’s effect have yet to be fully understood. The present study aims to investigate the involvement of the serotonergic system in cardamonin induced antihyperalgesic and antiallodynic effects in CCI-induced neuropathic pain mice model. The neuropathic pain symptoms in the CCI mice model were assessed using Hargreaves Plantar test and von-Frey filament test on day 14 post-surgery. Central depletion of serotonin along the descending serotonergic pathway was done using ρ-chlorophenylalanine (PCPA, 100 mg/kg, i.p.), an inhibitor of serotonin synthesis for four consecutive days before cardamonin treatment, and was found to reverse the antihyperalgesic and antiallodynic effect produced by cardamonin. Pretreatment of the mice with several 5-HT receptor subtypes antagonists: methiothepin (5-HT1/6/7(7) receptor antagonist, 0.1 mg/kg), WAY 100635 (5-HT1A receptor antagonist, 1 mg/kg), isamoltane (5-HT1B receptor antagonist, 2.5 mg/kg), ketanserin (5-HT2A receptor antagonist, 0.3 mg/kg), and ondansetron (5-HT3 receptor antagonist, 0.5 mg/kg) were shown to abolish the effect of cardamonin induced antihyperalgesic and antiallodynic effects. Further evaluation of the 5-HT1A receptor subtype protein expressions reveals that cardamonin significantly upregulated its expression in the brainstem and spinal cord. Our results suggest that the serotonergic pathway is essential for cardamonin to exert its antineuropathic effect in CCI mice through the involvement of the 5-HT1A receptor subtype in the central nervous system.
format Online
Article
Text
id pubmed-8234694
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82346942021-06-27 Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model Kaswan, Nur Khalisah Mohammed Izham, Noor Aishah Binti Tengku Mohamad, Tengku Azam Shah Sulaiman, Mohd Roslan Perimal, Enoch Kumar Molecules Article Cardamonin, a naturally occurring chalcone isolated from Alpinia species has shown to possess strong anti-inflammatory and anti-nociceptive activities. Previous studies have demonstrated that cardamonin exerts antihyperalgesic and antiallodynic properties in chronic constriction injury (CCI)-induced neuropathic pain animal model. However, the mechanisms underlying cardamonin’s effect have yet to be fully understood. The present study aims to investigate the involvement of the serotonergic system in cardamonin induced antihyperalgesic and antiallodynic effects in CCI-induced neuropathic pain mice model. The neuropathic pain symptoms in the CCI mice model were assessed using Hargreaves Plantar test and von-Frey filament test on day 14 post-surgery. Central depletion of serotonin along the descending serotonergic pathway was done using ρ-chlorophenylalanine (PCPA, 100 mg/kg, i.p.), an inhibitor of serotonin synthesis for four consecutive days before cardamonin treatment, and was found to reverse the antihyperalgesic and antiallodynic effect produced by cardamonin. Pretreatment of the mice with several 5-HT receptor subtypes antagonists: methiothepin (5-HT1/6/7(7) receptor antagonist, 0.1 mg/kg), WAY 100635 (5-HT1A receptor antagonist, 1 mg/kg), isamoltane (5-HT1B receptor antagonist, 2.5 mg/kg), ketanserin (5-HT2A receptor antagonist, 0.3 mg/kg), and ondansetron (5-HT3 receptor antagonist, 0.5 mg/kg) were shown to abolish the effect of cardamonin induced antihyperalgesic and antiallodynic effects. Further evaluation of the 5-HT1A receptor subtype protein expressions reveals that cardamonin significantly upregulated its expression in the brainstem and spinal cord. Our results suggest that the serotonergic pathway is essential for cardamonin to exert its antineuropathic effect in CCI mice through the involvement of the 5-HT1A receptor subtype in the central nervous system. MDPI 2021-06-16 /pmc/articles/PMC8234694/ /pubmed/34208700 http://dx.doi.org/10.3390/molecules26123677 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kaswan, Nur Khalisah
Mohammed Izham, Noor Aishah Binti
Tengku Mohamad, Tengku Azam Shah
Sulaiman, Mohd Roslan
Perimal, Enoch Kumar
Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model
title Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model
title_full Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model
title_fullStr Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model
title_full_unstemmed Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model
title_short Cardamonin Modulates Neuropathic Pain through the Possible Involvement of Serotonergic 5-HT1A Receptor Pathway in CCI-Induced Neuropathic Pain Mice Model
title_sort cardamonin modulates neuropathic pain through the possible involvement of serotonergic 5-ht1a receptor pathway in cci-induced neuropathic pain mice model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234694/
https://www.ncbi.nlm.nih.gov/pubmed/34208700
http://dx.doi.org/10.3390/molecules26123677
work_keys_str_mv AT kaswannurkhalisah cardamoninmodulatesneuropathicpainthroughthepossibleinvolvementofserotonergic5ht1areceptorpathwayincciinducedneuropathicpainmicemodel
AT mohammedizhamnooraishahbinti cardamoninmodulatesneuropathicpainthroughthepossibleinvolvementofserotonergic5ht1areceptorpathwayincciinducedneuropathicpainmicemodel
AT tengkumohamadtengkuazamshah cardamoninmodulatesneuropathicpainthroughthepossibleinvolvementofserotonergic5ht1areceptorpathwayincciinducedneuropathicpainmicemodel
AT sulaimanmohdroslan cardamoninmodulatesneuropathicpainthroughthepossibleinvolvementofserotonergic5ht1areceptorpathwayincciinducedneuropathicpainmicemodel
AT perimalenochkumar cardamoninmodulatesneuropathicpainthroughthepossibleinvolvementofserotonergic5ht1areceptorpathwayincciinducedneuropathicpainmicemodel